Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gregor

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|May 20, 2011
Antibody recognition of a human chorionic gonadotropin epitope (hCGbeta66-80) depends on local structure retained in the free peptideCraig R Gregor, Eleonora Cerasoli, James Schouten, et al.
Bioorganic & Medicinal Chemistry|July 6, 2000
Biaryl diacid inhibitors of human s-PLA2 with anti-inflammatory activityD M Springer, B Y Luh, J J Bronson, et al.
The Journal of Biological Chemistry|October 31, 2002
BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in miceJames R Burke, Mark A Pattoli, Kurt R Gregor, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 16, 2001
BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation modelsJ R Burke, L B Davern, P L Stanley, et al.
The Journal of Biological Chemistry|June 26, 1999
Competitive, reversible inhibition of cytosolic phospholipase A2 at the lipid-water interface by choline derivatives that partially partition into the phospholipid bilayerJ R Burke, M R Witmer, F C Zusi, et al.
Bioorganic & Medicinal Chemistry Letters|January 2, 2007
Synthesis and biological evaluation of 4-amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitorsFrancis Beaulieu, Carl Ouellet, Edward H Ruediger, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 5, 2009
Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritisKathleen M Gillooly, Mark A Pattoli, Tracy L Taylor, et al.
Journal of Medicinal Chemistry|December 2, 2020
Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design ApproachesHai-Yun Xiao, Ning Li, James J-W Duan, et al.
Physical Review Letters|March 21, 2015
Three-body nature of N(*) and Δ(*) resonances from sequential decay chainsA Thiel, V Sokhoyan, E Gutz, et al.
Physical Review Letters|June 4, 2008
Incoherent neutral pion photoproduction on 12CC M Tarbert, D P Watts, P Aguar, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|May 20, 2011
Antibody recognition of a human chorionic gonadotropin epitope (hCGbeta66-80) depends on local structure retained in the free peptideCraig R Gregor, Eleonora Cerasoli, James Schouten, et al.
Bioorganic & Medicinal Chemistry|July 6, 2000
Biaryl diacid inhibitors of human s-PLA2 with anti-inflammatory activityD M Springer, B Y Luh, J J Bronson, et al.
The Journal of Biological Chemistry|October 31, 2002
BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in miceJames R Burke, Mark A Pattoli, Kurt R Gregor, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 16, 2001
BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation modelsJ R Burke, L B Davern, P L Stanley, et al.
The Journal of Biological Chemistry|June 26, 1999
Competitive, reversible inhibition of cytosolic phospholipase A2 at the lipid-water interface by choline derivatives that partially partition into the phospholipid bilayerJ R Burke, M R Witmer, F C Zusi, et al.
Bioorganic & Medicinal Chemistry Letters|January 2, 2007
Synthesis and biological evaluation of 4-amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitorsFrancis Beaulieu, Carl Ouellet, Edward H Ruediger, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 5, 2009
Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritisKathleen M Gillooly, Mark A Pattoli, Tracy L Taylor, et al.
Journal of Medicinal Chemistry|December 2, 2020
Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design ApproachesHai-Yun Xiao, Ning Li, James J-W Duan, et al.
Physical Review Letters|March 21, 2015
Three-body nature of N(*) and Δ(*) resonances from sequential decay chainsA Thiel, V Sokhoyan, E Gutz, et al.
Physical Review Letters|June 4, 2008
Incoherent neutral pion photoproduction on 12CC M Tarbert, D P Watts, P Aguar, et al.
Pageof 5